Journal Club 2018

 PDF-Link for institution's members only (password required, see infoboard of UVCM, Inselspital) 

2018-08-08
  • Halkjær SI et al. Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study. Gut. 2018 Jul 6. pii: gutjnl-2018-316434. DOI-Link - PDF for institution members
  • Corpechot C et al. A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. N Engl J Med. 2018 Jun 7;378(23):2171-2181. DOI-Link - PDF for institution members

2018-07-18
  • Riva A et al. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease. Gut. 2018 May;67(5):918-930. DOI-Link - PDF for institution members
  • Burgess CJ.  Utility of proactive infliximab levels in paediatric Crohn's disease. Arch Dis Child. 2018 Jun 27. pii: archdischild-2018-315100. DOI-Link - PDF for institution members

2018-07-04
  • Nakajima A et al. Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial. Lancet Gastroenterol Hepatol. 2018 May 24. pii: S2468-1253(18)30123-7. DOI-Link - PDF for institution members
  • Sinclair M et al.  Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial. J Hepatol. 2016 Nov;65(5):906-913. DOI-Link - PDF for institution members

2018-06-06
  • Chen Q et al. Effect of Huaier granule on recurrence after curative resection of HCC: a multicentre, randomised clinical trial. Gut. 2018 May 25. pii: gutjnl-2018-315983. DOI-Link - PDF for institution members
  • Bennet SMP et al.  Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut. 2018 May;67(5):872-881. DOI-Link - PDF for institution members

2018-05-16
  • Abul-Husn NS et al: A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease. N Engl J Med. 2018 Mar 22;378(12):1096-1106. DOI-Link - PDF for institution members
  • Grander C et al: Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut. 2018 May;67(5):891-901. DOI-Link - PDF for institution members

2018-05-02
  • Colombel JF et al: Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial. Lancet. 2018 Dec 23;390(10114):2779-2789. DOI-Link - PDF for institution members
  • Moussata D et al: Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2018 Apr;67(4):616-624. DOI-Link - PDF for institution members

2018-04-18
  • Ge S et al: A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018 Mar 8;9(1):1012. DOI-Link - PDF for institution members
  • Chang SH et al: Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation. JAMA. 2017 Oct 3;318(13):1250-1259. DOI-Link - PDF for institution members

2018-04-04
  • Choi IJ et al: Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer. N Engl J Med. 2018 Mar 22;378(12):1085-1095. DOI-Link - PDF for institution members
  • Beyer G et al: Development and Validation of a Chronic Pancreatitis Prognosis Score in 2 Independent Cohorts. Gastroenterology. 2017 Dec;153(6):1544-1554.e2. DOI-Link - PDF for institution members

2018-03-21
  • Laine L et al: Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis. Am J Gastroenterol. 2018 Mar;113(3):358-366. DOI-Link - PDF for institution members

2018-03-07
  • Skodje GI et al: Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity. Gastroenterology. 2018 Feb;154(3):529-539.e2. DOI-Link - PDF for institution members
  • Reenaers C et al: Outcomes 7 Years After Infliximab Withdrawal for Patients With Crohn's Disease in Sustained Remission. Clin Gastroenterol Hepatol. 2018 Feb;16(2):234-243.e2. DOI-Link - PDF for institution members

2018-02-21
  • Ferreira RM et al: Gastric microbial community profiling reveals a dysbiotic cancer-associated microbiota. Gut. 2018 Feb;67(2):226-236. DOI-Link - PDF for institution members
  • Ozen A et al: CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. N Engl J Med. 2017 Jul 6;377(1):52-61. DOI-Link - PDF for institution members

2018-02-07
  • Mukewar SS et al: Open-Capsule Budesonide for Refractory Celiac Disease. Am J Gastroenterol. 2017 Jun;112(6):959-967. DOI-Link - PDF for institution members
  • Lorenzo D et al: Features of Autoimmune Pancreatitis Associated With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2018 Jan;16(1):59-67. DOI-Link - PDF for institution members

2018-01-17
  • Papamichael K et al: Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of Infliximab. Clin Gastroenterol Hepatol. 2017 Oct;15(10):1580-1588.e3. DOI-Link - PDF for institution members
  • Danese S et al: Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II). Gut. 2017 Dec 15. pii: gutjnl-2017-314562. DOI-Link - PDF for institution members

2018-01-03
  • Sarna VK et al: HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption. Gastroenterology. 2017 Nov 13. pii: S0016-5085(17)36352-7. DOI-Link - PDF for institution members
  • Colombel JF et al: Discrepancies between patient-reported outcomes, and endoscopic and histological appearance in UC. Gut. 2017 Dec;66(12):2063-2068. DOI-Link - PDF for institution members

  •  
  •  
  •  
  •  
© 2012-2015 Gastroenterology & Mucosal Immunology, Bern, Switzerland
Swiss Web Design